Indivior Wants 3rd Circ. To Undo Suboxone Class Cert.
Indivior Inc. implored the Third Circuit to undo certification of a class action accusing the company of delaying generic competition of its opioid addiction drug Suboxone, arguing Wednesday that certification was...To view the full article, register now.
Already a subscriber? Click here to view full article